Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection.
Gastón J PiñeiroErika De Sousa-AmorimManel SoléJosé RíosMiguel LozanoFrederic CofánPedro Ventura-AguiarDavid CucchiariIgnacio RevueltaJoan CidEduard PalouJosep M CampistolFederico OppenheimerJordi RoviraFritz DiekmannPublished in: BMC nephrology (2018)
Agencia Española de Medicametos y Productos Sanitarios (AEMPS): 14566/RG 24161. Study code: UTR-INM-2017-01.